Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,885 papers from all fields of science
Search
Sign In
Create Free Account
2 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe [Euflexxa]
Known as:
2 ML Euflexxa 10 MG/ML Prefilled Syringe
, HYALURONATE NA (EUFLEXXA) 10MG/ML INJ,SYRINGE,2ML [VA Product]
, HYALURONATE NA (EUFLEXXA) 10MG/ML INJ,SYRINGE,2ML
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
Drug Allergy
Euflexxa
Pain
Prefilled Syringe
Expand
Broader (2)
Other antirheumatics
hyaluronate Prefilled Syringe [Euflexxa]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Biomimetic proteoglycans can molecularly engineer early osteoarthritic cartilage in vivo
Evan R Phillips
,
K. Prudnikova
,
+6 authors
M. Marcolongo
Journal of Orthopaedic Research
2019
Corpus ID: 53731643
Biomimetic proteoglycans (BPGs) have the potential to treat osteoarthritis (OA) given that these molecules mimic the structure…
Expand
2013
2013
Assessment of the health-related quality of life impact of Euflexxa® (1% sodium hyaluronate) using the short form (SF)-36 data collected in a randomized clinical trial
H. Hatoum
,
JE Rosen
,
Anke L Fierlinger
,
Swu-Jane Lin
,
R. Altman
2013
Corpus ID: 76257854
2011
2011
Safety and efficacy of retreatment with a bioengineered hyaluronate for painful osteoarthritis of the knee: results of the open-label Extension Study of the FLEXX Trial.
R. Altman
,
JE Rosen
,
JE Rosen
,
JE Rosen
,
D. Bloch
,
H. Hatoum
Osteoarthritis and Cartilage
2011
Corpus ID: 206303303
2009
2009
503 26-WEEK EXTENSION OF A 26-WEEK TRIAL OF INTRA-ARTICULAR HYALURONATE (EUFLEXXA®) IN OSTEOARTHRITIS OF THE KNEE (THE FLEXX TRIAL)
R. Altman
,
J. Rosen
,
P. Korner
2009
Corpus ID: 72014833
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE